Keywords: fda, considering, strong, warning, byetta, potential, fall-out

FDA considering strong warning on Byetta; potential fall-out for all GLP-1 analogs

Article | 01 September 2008

Print This

The US Food and Drug Administration is considering strengthening the label for diabetes drug Byetta (exenatide), calling into question the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in